With increasing research on the immune regulatory mechanism of low-dose IL-2, IL-2 has gained attention as a potential treatment for various immunological diseases, such as graft-versus-host disease (GvHD) (67), hepatitis C–related vasculitis (68), and type 1 diabetes (69). Here, IL2 is linked to type 1 diabetes mellitus.